Women less likely than men to receive retinal detachment repair

November 24, 2020

According to an abstract presented during the 2020 Virtual Retina Society Annual Meeting, women are 34% less likely to receive a repair for a retinal detachment compared with men.

Schepens Lecturer Russell Van Gelder, MD, PhD: Could small molecule photoswitches be the ‘miracle’ of vision restoration?

November 23, 2020

Thanks to researchers like Russell N. Van Gelder, MD, PhD, the possibility of restoring sight to people blinded by age-related macular degeneration or retinitis pigmentosa is another step closer to reality.

Advancement in the management of wet age-related macular degeneration

November 19, 2020

Caroline R Baumal, MD, Thomas Albini, MD, Aleksandra Rachitskaya, MD, and Michael Singer, MD, discuss a number of topics pertaining to wet age-related macular degeneration (wet AMD) including the diagnosis and clinical manifestations, treatment options, and the impact of the COVID-19 pandemic on management of wet AMD.

AAO 2020: Drop-free prophylaxis regimen before cataract surgery lowers treatment burden with caveats

November 15, 2020

During AAO 2020, Neal H. Shorstein, MD, explains how physicians at Kaiser Permanente have a streamlined regimen using a prophylactic drop-free drug before cataract surgery for more than a decade.

AAO 2020: Preventing cystoid macular oedema after cataract surgery

November 15, 2020

Rudy Nuijts of the University Eye Clinic Maastricht, the Netherlands, discusses the highlights of his AAO 2020 presentation on a combination treatment regimen for lowering the incidence of cystoid macular oedema following category surgery.

AAO 2020: Alcon showcases advanced IOL technology for presbyopia

November 15, 2020

Kristen Brotherson, vice president, US surgical marketing for Alcon, discusses some of the recent advances in cataract surgery-related technologies, including a new advanced lens for patients with presbyopia (AcrySof IQ Vivity IOL).

AAO 2020: Medication could reduce burden of steroid drops for patients

November 15, 2020

Cynthia Matossian, MD, FACS, ABES presents the highlights of a poster on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications.

AAO 2020: Alimera highlights NEW DAY Study for sustained-release intravitreal implant

November 15, 2020

Rick Eiswirth, president and CEO of Alimera Sciences, provides an update on the company’s clinical trial that aims to evaluate its fluocinolone acetonide intravitreal implant 0.19 mg (Iluvien) as a baseline therapy for diabetic macular edema.